Table 1.
Study attributes/characteristics of groups studied | |
---|---|
Inclusion criteria | |
Study design | Population-based observational studies and (experiment) trials: case–control, cohort and case-series |
Population/age | Children and/or adolescents (0–19 yearsa) |
Outcome | Obesity and/or related metabolic abnormalities (impaired glucose tolerance, insulin resistance, prediabetes, diabetes mellitus type 2, metabolic syndrome) in metabolomics research |
Biofluid | Blood (serum and plasma), urine, excretion, faeces, saliva, tissue, hair, nails |
Diagnostics | Clinician-based: BMI diagnostic criteria, oral glucose tolerance test, parameters/criteria for metabolic syndrome, cardiovascular disease risk, non-alcoholic fatty liver disease, etc |
Exclusion criteria | |
Language | Language other than English |
Document type | Other than article (e.g. review, letters, conference abstracts) |
Age/disease | Study population of adults only and in utero/maternal studies (e.g. gestational diabetes), participant population with any thyroid or metabolic disorder under treatment (e.g. diabetes, cardiovascular disease) |
Type of study | Exposure study, genomics, transcriptomics, proteomics, microbiomics and intervention studies |
A detailed description of the in- and exclusion criteria on the basis of which articles were retrieved and selected articles were withheld for final assessment
aBased on WHO definition